Biotech 2050 Podcast cover image

Stephanie Sirota, CBO & Partner at RTW Investments, on Biotech Investing, Policy & Bold Bet Building

Biotech 2050 Podcast

00:00

Emerging Opportunities in GLP and Metabolic Disease Drug Development

This chapter explores the burgeoning potential of GLP drugs, discussing recent advancements and competitive dynamics in the pharmaceutical landscape. It also highlights future opportunities in metabolic disease treatments driven by emerging private-sector innovations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app